Navigation Links
TI EEG analog front end lowers noise more than 75 percent for non-invasive brain wave monitoring
Date:9/10/2012

DALLAS, Sept. 10, 2012 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NASDAQ: TXN) expanded its award-winning ADS1298 analog front end (AFE) family today with the industry's lowest-noise electroencephalography (EEG) AFE, enabling non-invasive monitoring of brain waves. The 24-bit, 8-channel ADS1299 is the first simultaneously sampling EEG AFE with input-referred-noise as low as 1 uVpp, more than 75-percent lower than the alternative EEG AFEs. When used in a 32-electrode EEG, the device also reduces board space by 70 percent while reducing bill of materials (BOM) 40 percent. For information or to order samples, visit www.ti.com/ads1299-pr.

The ADS1299 was designed for manufacturers of extra-cranial biopotential measurement equipment who want to reduce board space, design time and cost while improving performance. It can be used in EEG equipment to monitor bispectral index, evoked potentials and event-related potentials to diagnose brain injuries, strokes and sleep disorders. The ADS1299 can also be used in ultra-high-performance medical diagnostic and research-grade electrocardiogram (ECG) equipment.

Key features and benefits of the ADS1299:

  • Reduces board space, BOM cost:
    • Integrates eight low-noise programmable gain amplifiers, eight high-resolution analog-to-digital converters (ADCs), test signals, bias amplifier, oscillator and reference.
    • When used in a 32-electrode EEG, the ADS1299 significantly reduces board space and BOM compared to alternative EEG AFEs, which provide fewer channels and require additional external components to reduce noise.  
  • Highest performance available: With input-referred noise as low as 1 uVpp at 70-Hz bandwidth and a common mode rejection ratio of -120 dB, 10-dB better than the competition, the ADS1299 enables extra-cranial biopotential measurement, even in the presence of large electromagnetic interference signals.
  • Increases equipment reliability: Continuous lead-off detection option notifies medical staff when electrodes disconnect.
  • Pin-compatible to reduce design costs, decrease time to market: Pin compatible with the following devices in the ADS1298 family: eight-channel ADS1298, ADS1298R and ADS1198; six-channel ADS1296, ADS1296R and ADS1196; four-channel ADS1294, ADS1294R and ADS1194. This enables medical equipment manufacturers to design complete lines of products with one EEG/ECG device family, reducing overall design costs and significantly decreasing time to market.

Tools and support
The ADS1299 Performance Demonstration Kit (ADS1299EEG-FE) includes easy-to-use evaluation software; built-in analysis tools, including oscilloscope, FFT and histogram displays; flexible input configurations; optional external reference circuits; and the ability to export data in simple test files for post processing. An IBIS model to verify board signal integrity requirements is also available.

Availability and packaging
The ADS1299 is available today in a 10-mm by 10-mm QFP package for $US36 in 1,000-unit quantities.

Find out more about TI's analog front end and medical portfolio at the links below:

About Texas Instruments
Texas Instruments semiconductor innovations help 90,000 customers unlock the possibilities of the world as it could be – smarter, safer, greener, healthier and more fun.  Our commitment to building a better future is ingrained in everything we do – from the responsible manufacturing of our semiconductors, to caring for our employees, to giving back inside our communities.  This is just the beginning of our story.  Learn more at www.ti.com.

Trademarks
TI E2E is a trademark of Texas Instruments. All other trademarks and registered trademarks belong to their respective owners.


'/>"/>
SOURCE Texas Instruments Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Analog Integrated Circuits (IC) Market to 2016 - Electric Vehicles and Portable Medical Equipment Segments to be Main Source of Future Growth
2. TI introduces the industrys first weigh scale and body composition analog front end
3. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
4. From Cloning Dolly the Sheep to Curing Blindness, Scotland is on the Forefront of Life Science Discoveries
5. Hill-Rom Reports Fiscal Third Quarter Results; Announces Aspen Surgical Acquisition; Lowers Full Year Financial Outlook
6. GlaxoSmithKlines (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of Americas Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers Attorneys Say
7. New Analysis Shows Illicit Drug Use May Vary by Payer Type: Detection Rates as High as 17 Percent
8. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
9. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
10. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
11. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 20, 2017 Research and Markets has ... Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), ... of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" ... ... healthcare services, market segments, especially clinical lab testing, which has ...
(Date:1/21/2017)... DUBLIN , Jan 20, 2017 Research ... Delivery Market Analysis & Trends - Technology, Route Of Administration, End ... ... Delivery Market is poised to grow at a CAGR of around ... 2025. This industry report analyzes the global markets ...
(Date:1/20/2017)... -- Stock-Callers.com today evaluates the following Drug Manufacturers ... Nordisk A/S (NYSE: NVO ), Sucampo Pharmaceuticals Inc. ... (NASDAQ: PTX ). These stocks belong to the ... 2017, finishing near its session lows. As per a NASDAQ ... shares of health care companies in the S&P 500 also ...
Breaking Medicine Technology:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... and production applications. However, choosing the right method is paramount to success. Selecting ... more often in situations where multiple persons use the same equipment. Rare or ...
(Date:1/23/2017)... Angeles, California (PRWEB) , ... January 23, 2017 , ... ... Era” principles, has added Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing ... began competing as a bodybuilder in 2012 and in less than a year was ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “The Inn at the Mill”: a ... unexpected fears in her quest to become happy and content. , “The Inn at ... Pennsylvania, has also lived in Germany and Vermont and is now living in Berks County ...
(Date:1/23/2017)... ... , ... “Life Under Blankets”: an entrancing story about one woman's travels ... is the creation of published author, Kimberly Mitchell, who earned her bachelor’s degree in ... to pursue a master’s degree in education in the field of curriculum and instruction. ...
(Date:1/22/2017)... ... ... Phytocéane invites clients to take an exotic journey deep into the heart ... CREAM. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the coast of ... to create this gentle, velvety body cream to envelop the skin in moisture while ...
Breaking Medicine News(10 mins):